AstraZeneca to set up division for vaccines and antibody therapies
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Friday
February 03, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
FRIDAY, FEBRUARY 03, 2023
AstraZeneca to set up division for vaccines and antibody therapies

Coronavirus chronicle

Reuters
10 November, 2021, 09:50 am
Last modified: 10 November, 2021, 09:55 am

Related News

  • Rally, scientific seminar to prevent cervical cancer held at Labaid Hospital
  • Updated Covid vaccines prevented illness from latest variants -CDC
  • Vaccine misinformation spawns 'pure blood' movement
  • icddr,b scientists discover mother-to-child Nipah antibody transfer
  • World renowned Vaccinologist Professor Dame Sarah Gilbert visits Incepta Pharma

AstraZeneca to set up division for vaccines and antibody therapies

The company's Covid-19 shot is the biggest contributor to the COVAX vaccine sharing scheme backed by the WHO

Reuters
10 November, 2021, 09:50 am
Last modified: 10 November, 2021, 09:55 am
A vial of the AstraZeneca vaccine for the coronavirus disease (Covid-19) at one of the Youth centres where citizens can get the vaccines without prior registration, in an effort to boost the country's vaccination drive, in Cairo, Egypt, September 27, 2021. Photo :Reuters
A vial of the AstraZeneca vaccine for the coronavirus disease (Covid-19) at one of the Youth centres where citizens can get the vaccines without prior registration, in an effort to boost the country's vaccination drive, in Cairo, Egypt, September 27, 2021. Photo :Reuters

* News comes after review of vaccine operations

* Covid-19 shot has suffered setbacks during pandemic

* Company has antibody therapy proven to prevent infection

* Move shows company sees future for Covid-19 vaccine beyond pandemic


AstraZeneca is creating a separate division for vaccines and antibody therapies, the drugmaker said on Tuesday, to focus on its Covid-19 shot and coronavirus treatments after a series of setbacks during the pandemic.

Reuters reported in July that the Anglo-Swedish company was exploring options https://reut.rs/3bTjnX5 for its vaccine business and expected to have greater clarity on the matter by the end of 2021.

The new division, which will be led by executive vice-president of Europe and Canada, Iskra Reic, will combine research and development, manufacturing, as well as commercial and medical teams, a company spokesperson said.

"The team will be dedicated to our Covid-19 vaccine, our long-acting antibody combination and our developmental vaccine addressing multiple variants of concern, as well as to our existing portfolio for respiratory viral disease," the representative said.

The decision to set up a new business comes after a tumultuous 18 months for the drugmaker, which developed its Covid-19 vaccine in conjunction with the University of Oxford.

Production problems forced the company to cut deliveries to the European Union this year, prompting the bloc to launch a legal challenge that has now been settled.

Governments have also restricted its use among certain age groups due to links to rare blood clots. Regulators including the World Health Organization (WHO) have said, however, that the vaccine's overall benefits outweigh any risks.

AstraZeneca's application for US approval of its shot is taking longer than expected too.

But positive results from trials of its antibody cocktail as a preventative shot against Covid-19 have given AstraZeneca a major boost, potentially positioning it as a supplier of both Covid-19 vaccines and treatments. The antibody treatment is currently under review by European regulators.

BROADER MARKET?

The creation of the vaccines division, first reported by the Financial Times, indicates AstraZeneca sees a future for its Covid-19 shot beyond the pandemic but shouldn't be taken as a sign it is planning a full-scale entry into the broader vaccine market, Hargreaves Lansdown analyst Nicholas Hyett said.

"That would require significant new research and development investment, and as yet we have no indication that this is forthcoming," he said.

AstraZeneca has pledged to supply vaccines at cost during the pandemic. The not-for-profit strategy and challenges with the shot had fuelled speculation about whether it would want to keep the business in the long term.

The company's Covid-19 shot is the biggest contributor to the COVAX vaccine sharing scheme backed by the WHO.

"Vaccines is not a traditional area of strength (for AstraZeneca) ... but the new group structure suggests the company is looking to pull together certain operations across its portfolio to ensure they operate more effectively and more profitably," AJ Bell investment director Russ Mould said.

While AstraZeneca's Covid-19 vaccine remained a drag on profits in the second quarter, sales of the shot more than tripled to $894 million from the first three months of the year, making it one of the drugmaker's best-selling products.

AstraZeneca is due to report third-quarter results on Friday.

Top News / World+Biz

AstraZeneca / Vaccine / antibody

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • International Monetary Fund logo : AP via UNB
    IMF sets time-bound reform agenda as it releases first tranche of loan
  • Shipped Bhola gas to cost higher, yet cheaper than spot LNG
    Shipped Bhola gas to cost higher, yet cheaper than spot LNG
  • The trio spearheading the revival of book cover designs
    The trio spearheading the revival of book cover designs

MOST VIEWED

  • Tourists ride a tour bus in Hong Kong, China October 25, 2019. REUTERS/Ammar Awad
    Hong Kong says 'hello' to woo back visitors after Covid
  • People wearing face masks following the coronavirus disease (Covid-19) outbreak are seen at Beijing Daxing International Airport in Beijing, China July 23, 2020. Photo:Reuters
    Pandemic to paradise: Chinese tourists return to Bali after three years
  • People walk outside wearing masks during the coronavirus disease (COVID-19) pandemic in the Harlem area of the Manhattan borough of New York City, New York, U.S., February 10, 2022. REUTERS/Carlo Allegri
    US to end Covid-19 emergency declarations on 11 May
  • A nurse prepares a shot for Jonathan Halter as the German embassy begins its roll out of BioNTech COVID-19 vaccines for German expatriates at a Beijing United Family hospital in Beijing, China January 5, 2023. REUTERS/Thomas Peter/File Photo
    Covid remains a public health emergency, says WHO
  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs

Related News

  • Rally, scientific seminar to prevent cervical cancer held at Labaid Hospital
  • Updated Covid vaccines prevented illness from latest variants -CDC
  • Vaccine misinformation spawns 'pure blood' movement
  • icddr,b scientists discover mother-to-child Nipah antibody transfer
  • World renowned Vaccinologist Professor Dame Sarah Gilbert visits Incepta Pharma

Features

Andy Mukherjee. Sketch: TBS

What makes India's billionaires' support special for Adani

1h | Panorama
Photo: Rejaul Hafiz Rahi

A jackal farewell

2h | Earth
The trio spearheading the revival of book cover designs

The trio spearheading the revival of book cover designs

3h | Panorama
Six Jeep Wranglers and a special XJ Jeep Cherokee set out into the depths of Lalakhal, Sylhet for an experience of a lifetime. Photo: Ahbaar Mohammad

Jeep Life Bangladesh: A club for Jeep owners to harness the power of their vehicles

1d | Wheels

More Videos from TBS

A proper price formula can help investors to plan big

A proper price formula can help investors to plan big

18h | TBS Round Table
Rumors about Sarika that everyone thinks are true

Rumors about Sarika that everyone thinks are true

16h | TBS Entertainment
Mugging rife in Tejgaon, murder in Wari

Mugging rife in Tejgaon, murder in Wari

19h | TBS Current Affairs
What secrets are hidden behind Adani's wealth?

What secrets are hidden behind Adani's wealth?

17h | TBS Stories

Most Read

1
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

2
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

3
Photo: Collected
Energy

8 Ctg power plants out of production

4
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

5
Photo: Collected
Court

Japanese mother gets guardianship of daughters, free to leave country

6
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]